FibroBiologics (FBLG) EGM 2026 summary

Opening remarks and agenda

• Meeting called to order with introductions of board members and executive team.

• Agenda included formal business, a corporate update, and a Q&A session.

Specific resolutions to be voted on

• Sole proposal: approval of issuance of up to 8,163,266 shares of common stock upon exercise of warrants from a June 25, 2026 agreement, and up to 285,714 shares from an engagement letter.

• Board recommended voting in favor of the proposal.

Overview of voting outcomes

• Quorum established with 41% of eligible votes represented.

• Proposal to issue new shares was approved.

• Preliminary results to be reported in a Form 8-K within four business days.